UPDATE : Monday, September 7, 2020
상단여백
Anti-Alzheimer drink has no efficacy: civic group
Medical experts are increasingly raising suspicions over whether Handok’s n...
by So Jae-hyeon  |  2018-10-24 15:22
라인
Sales of antidiabetic SGLT-2 inhibitors expand in Q3
Antidiabetic drugs using sodium-glucose cotransporter 2 (SGLT-2) inhibitor ...
by So Jae-hyeon  |  2018-10-23 14:26
라인
Shingles vaccines likely to become cheaper
With local shingles vaccines rolled out, the prices of shingles vaccines ar...
by So Jae-hyeon  |  2018-10-22 17:05
라인
L&C BIO sets offering price at ₩24,000 for KOSDAQ debut
L&C BIO, a tissue engineering company, said on Friday that it has set its o...
by So Jae-hyeon  |  2018-10-22 14:12
라인
Trivalent flu shots out of stock, quadrivalent products selling poorly
Pharmaceutical companies aggressively marketed new quadrivalent flu vaccine...
by So Jae-hyeon  |  2018-10-18 13:59
라인
Developing natural product-derived drugs gets trickier under Nagoya Protocol
Korean pharmaceutical companies are struggling to develop new drugs out of ...
by So Jae-hyeon  |  2018-10-18 12:00
라인
Drug regulator raids 4 cell therapy makers
The pharmaceutical industry is paying keen attention to why the Ministry of...
by So Jae-hyeon  |  2018-10-16 15:28
라인
‘AI-based drug development to broaden gap between pharmaceuticals’
Local pharmaceutical firms should brace for a new era where drugmakers take...
by So Jae-hyeon  |  2018-10-15 15:37
라인
[News Focus] Handok sidesteps regulation to promote anti-Alzheimer drink
The medical community and pharmaceutical industry have raised suspicion tha...
by So Jae-hyeon  |  2018-10-15 14:52
라인
[News Focus] Celltrion to accelerate US entry on imminent FDA approval
Cellrion is expected to accelerate its move to enter the U.S. market with a...
by So Jae-hyeon  |  2018-10-12 15:40
라인
[News Focus] Authorities close in on drug firm owners in bribery case
The issue of illegal rebates is stirring the Korean pharmaceutical sector, ...
by So Jae-hyeon  |  2018-10-11 16:33
라인
Kukje Pharm CEO, executives booked for bribing doctors
A midsize Korean pharmaceutical company has been embroiled in an illegal re...
by So Jae-hyeon  |  2018-10-10 15:31
라인
Pharmaceuticals seek fresh start with new CEOs
Several pharmaceutical and biotech firms have appointed a new CEO or a vice...
by So Jae-hyeon  |  2018-10-05 15:44
라인
Daewoong to refile clinical trial plan on botulinum toxin in China
Daewoong Pharmaceutical has changed its strategy of entering the Chinese ma...
by So Jae-hyeon  |  2018-10-05 12:00
라인
GC LabCell seeks to expand indication of natural killer cell-based therapy
GC LabCell said Thursday it has received regulatory approval for a phase-1/...
by So Jae-hyeon  |  2018-10-04 14:51
라인
Pharma event to showcase AI-based solutions for new drug development
The Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA) a...
by So Jae-hyeon  |  2018-10-01 13:34
라인
Original hypertension drugs enjoy sales growth after valsartan recall
Original hypertension treatments by multinational pharmaceuticals achieved ...
by So Jae-hyeon  |  2018-09-28 15:55
라인
Korea, Belgium to hold first joint pharmaceutical conference
Korea and Belgium will hold their first joint pharmaceutical conference in ...
by So Jae-hyeon  |  2018-09-21 12:12
라인
Biois registers patent to develop TNF-alpha inhibitor
Biois Corp. said it has registered a patent on aptamers binding to tumor ne...
by So Jae-hyeon  |  2018-09-20 16:45
라인
Botulinum toxin makers to wage war in US, China in 2019
Korean makers of botulinum toxin are likely to compete against one another ...
by So Jae-hyeon  |  2018-09-18 11:51
여백
여백
여백
Back to Top